CA3028014C — Crystal forms of a 9-aminomethyl substituted tetracycline compound and a preparation method thereof
Assigned to KBP Biosciences Co Ltd · Expires 2021-09-07 · 5y expired
What this patent protects
The present invention relates to a crystal form of 9-aminomethyl substituted tetracycline compounds and a preparation method therefor, and in particular, to a crystal form of the compound represented by formula (I), a preparation method for a crystal form of the compound represen…
USPTO Abstract
The present invention relates to a crystal form of 9-aminomethyl substituted tetracycline compounds and a preparation method therefor, and in particular, to a crystal form of the compound represented by formula (I), a preparation method for a crystal form of the compound represented by formula (I) and use of the crystal form in the preparation of drugs for treating and/or preventing infectious diseases caused by tetracycline sensitive bacteria and/or tetracycline resistant bacteria.
Drugs covered by this patent
- Tygacil (TIGECYCLINE) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.